The vast majority (95 percent) of U.S. physicians believe that the COVID-19 pandemic has revealed vulnerabilities in the medicines supply chain that are not going away, and seven out of 10 (73 percent) feel their trust in the ability of the supply chain to deliver safe, quality medicines has eroded, according to a survey released by U.S. Pharmacopeia, a global independent scientific organization. A large majority believe the responsibility for solutions falls on multiple stakeholders. Nine out of 10 physicians surveyed (90 percent) said they are concerned that the global medicines supply chain may not be reliable in a time of crisis.
“As Congress considers bipartisan legislation on pandemic preparedness, the survey results further strengthen the case to meaningfully address medicines supply chain vulnerabilities, including the potential for drug shortages, before the next public health crisis,” said Ronald T. Piervincenzi, PhD, CEO of USP. More information about the survey is available here.
